Why the study?
Does prophylactic low molecular weight dextran prevent thromboembolism in patients undergoing elective surgery of the hip?
Population
Patients undergoing elective surgery of the hip (n=106 operations)
Design
Other
Authors
Loading...
May support dextran prophylaxis after elective hip surgery; leaves open confirmation in randomized trials.
Does prophylactic low molecular weight dextran prevent thromboembolism in patients undergoing elective surgery of the hip?
Prophylactic administration of low molecular weight dextran is effective and safe for preventing thromboembolism after elective hip surgery.
Evarts et al. (1971) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: